13F-HR filed by Finepoint Capital LP
Finepoint Capital LP filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-12, with 60 holding rows worth $289,206,000.
- Accession
- 0001567619-22-015687
- Filer
- CIK 1608126
- Filed
- 2022-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 60 entries on the cover page, a total value of $289,206,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $289,213,000 with VALUE read as thousands by filing date, 13F file number 028-16580. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALGOMA STL GROUP INC | 015658107 | COM | 3,716,732 | $33,376,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,010,900 | $21,597,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 52,800 | $20,005,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 419,433 | $16,480,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 211,000 | $15,817,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 475,600 | $15,362,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 474,000 | $15,144,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 159,500 | $14,827,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 259,400 | $14,475,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 318,400 | $14,398,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 584,300 | $14,158,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 210,200 | $14,111,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 535,000 | $13,557,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 457,500 | $12,421,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 203,200 | $12,123,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 960,200 | $10,601,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 707,200 | $9,964,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 987,600 | $9,501,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 735,126 | $5,815,000 | thousands by filing date | |
| Global Business Travel Group I | 37890B118 | Warrant | 913,000 | $959,000 | thousands by filing date | |
| COHN ROBBINS HOLDINGS CORP | G23726113 | *W EXP 08/28/202 | 904,000 | $389,000 | thousands by filing date | |
| SOCIAL CAPITAL HEDOSOPHA HLDWT | G8251L113 | WARRANT AND RIGH | 671,000 | $322,000 | thousands by filing date | |
| STARRY GROUP HOLDINGS INC | 85572U110 | WTS | 669,000 | $276,000 | thousands by filing date | |
| KKR ACQUISITION HOLDING I CO | 48253T117 | WTS | 588,547 | $212,000 | thousands by filing date | |
| BRIDGETOWN HOLDINGS LTD | G1355U121 | *W EXP 09/30/202 | 895,000 | $206,000 | thousands by filing date | |
| CHURCHILL CAPITAL CORP V | 17144T115 | *W EXP 10/29/202 | 612,000 | $202,000 | thousands by filing date | |
| Gores Technology Partners II Inc | 38287L115 | Warrant | 450,691 | $198,000 | thousands by filing date | |
| CHURCHILL CAPITAL CORP VII | 17144M110 | *W EXP 02/29/202 | 548,000 | $191,000 | thousands by filing date | |
| CHURCHILL CAPITAL CORP VI | 17143W119 | *W EXP 02/17/202 | 540,000 | $184,000 | thousands by filing date | |
| CONYERS PARK III ACQSITN COR | 21289P110 | *W EXP 08/12/202 | 571,666 | $166,000 | thousands by filing date | |
| JAWS HURRICANE ACQUISITN COR | 47201B111 | *W EXP 03/26/202 | 387,249 | $139,000 | thousands by filing date | |
| HOME PLATE ACQUISITION CORP | 43734R111 | *W EXP 09/30/202 | 690,000 | $124,000 | thousands by filing date | |
| BERENSON ACQUISITION CORP I | 083690115 | *W EXP 08/01/202 | 862,499 | $121,000 | thousands by filing date | |
| ARES ACQUISITION CORPORATION | G33032122 | *W EXP 02/02/202 | 504,706 | $116,000 | thousands by filing date | |
| COMPASS DIGITAL ACQUISITION CO | g2476c123 | WT | 459,906 | $115,000 | thousands by filing date | |
| ZIMMER ENERGY TRANSITION ACQ | 989570114 | *W EXP 06/16/202 | 358,270 | $115,000 | thousands by filing date | |
| REVOLUTION HEALTHCAR AQ CORP | 76155Y116 | *W EXP 12/31/202 | 432,639 | $108,000 | thousands by filing date | |
| GORES TECHNOLOGY PARTNERS IN | 382870111 | *W EXP 03/16/202 | 201,000 | $105,000 | thousands by filing date | |
| CONCORD ACQUISITION II CORP | 20607u116 | WT | 408,333 | $90,000 | thousands by filing date | |
| HEALTH ASSURN ACQUISITION CO | 42226W117 | *W EXP 11/12/202 | 643,000 | $87,000 | thousands by filing date | |
| MARBLEGATE ACQUISITION CORP | 56608A113 | *W EXP 08/31/202 | 735,000 | $74,000 | thousands by filing date | |
| FORTRESS CAPITAL ACQUISITION | G36427121 | WARR | 392,000 | $71,000 | thousands by filing date | |
| SENIOR CONNECT ACQUISITN COR | 81723H116 | *W EXP 12/31/202 | 1,014,000 | $71,000 | thousands by filing date | |
| CATALYST PARTNRS ACQUISITN C | G19550121 | *W EXP 05/12/202 | 336,666 | $71,000 | thousands by filing date | |
| AFTERNEXT HEALTHTECH ACQUISI | G01109126 | *W EXP 99/99/999 | 366,666 | $70,000 | thousands by filing date | |
| EQUITY DISTR ACQUISITION COR | 29465E114 | *W EXP 09/09/202 | 669,000 | $69,000 | thousands by filing date | |
| ROSS ACQUISITION II CORP | g7641c114 | WT | 439,666 | $68,000 | thousands by filing date | |
| CORSAIR PARTNERING CORP | G2540H116 | *W EXP 07/06/202 | 334,666 | $67,000 | thousands by filing date | |
| SIMON PROPERTY GRP ACQ HOLDI | 82880R111 | *W EXP 02/04/202 | 335,200 | $62,000 | thousands by filing date | |
| CALIDI BIOTHERAPEUTICS INC | 320703119 | *W EXP 03/14/202 | 655,200 | $59,000 | thousands by filing date | |
| FORTRESS VALUE ACQUISI CORP | 34964K116 | *W EXP 03/18/202 | 306,513 | $57,000 | thousands by filing date | |
| BILANDER ACQUISITION CORP | 09001T114 | *W EXP 05/19/202 | 183,749 | $55,000 | thousands by filing date | |
| SWIFTMERGE ACQUISITION CORP | G63836111 | *W EXP 12/13/202 | 490,000 | $54,000 | thousands by filing date | |
| SKYDECK ACQUISITION CORP | G82220115 | *W EXP 05/13/202 | 361,756 | $54,000 | thousands by filing date | |
| SUMMIT HEALTHCRE ACQUISTN CO | G8566R110 | *W EXP 06/03/202 | 489,999 | $45,000 | thousands by filing date | |
| FORTRESS VALUE ACQUIS CORP I | 34964G115 | *W EXP 12/31/202 | 225,000 | $41,000 | thousands by filing date | |
| WARBURG PINCUS CAPTAL CORP I | G9460M124 | WARR | 125,000 | $34,000 | thousands by filing date | |
| LEVERE HOLDINGS CORP | G5462L122 | *W EXP 03/09/202 | 274,999 | $22,000 | thousands by filing date | |
| THE MUSIC ACQUISITION CORP | 62752R118 | *W EXP 02/05/202 | 75,250 | $7,000 | thousands by filing date | |
| Warburg Pincus Capital Corp I-A | G9461D115 | Warrant | 14,999 | $5,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001567619-22-015687 | this filing | 2022-08-12 | acceptance time not in the bulk data set |